about
A simple practice guide for dose conversion between animals and humanAn Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic DrugsOral buccoadhesive films of ondansetron: Development and evaluationAn overview of nutraceuticals: current scenario.In vitro techniques to evaluate buccal films.Potential of plant mucilages in pharmaceuticals and therapy.Understanding type 1 diabetes: etiology and models.Prospects of iontophoresis in cardiovascular drug delivery.Novel Approaches in Formulation and Drug Delivery using Contact Lenses.Therapeutic drug monitoring by reverse iontophoresisControlled release matrix uncoated tablets of enalapril maleate using hpmc aloneDesign and evaluation of hydrophobic coated buoyant core as floating drug delivery system for sustained release of cisapride.Formulation and evaluation of enteric coated tablets of proton pump inhibitor.Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir.Simple spectrophotometric method for estimation of disodium edetate in topical gel formulations.Quantification of uptake and clearance of acyclovir in skin layers.Nanoparticle formulation by Büchi B-90 Nano Spray Dryer for oral mucoadhesionSimultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometryEnhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.Trans-ungual iontophoretic delivery of terbinafine.Pharmacokinetics and tissue distribution of spray-dried carboplatin microspheres: lung targeting via intravenous route.Evaluation of two pretreatment methods for the detection of Mycobacterium tuberculosis in suspected pulmonary tuberculosis.Skin uptake and clearance of ciclopirox following topical application.Assessment of pharmacokinetic interaction of spirulina with glitazone in a type 2 diabetes rat model.Buccal films of prednisolone with enhanced bioavailability.Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.A study on the effect of inorganic salts in transungual drug delivery of terbinafine.In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.Enhanced oral bioavailability of calcium using bovine serum albumin microspheres.Development and evaluation of buccal films impregnated with selegiline-loaded nanospheres.Long-Term Storage at -80°C: Effect on Rate of Recovery of Mycobacterium tuberculosis From Direct Acid-Fast Bacilli Smear-Positive Sputum Samples.An updated overview with simple and practical approach for developing in vitro-in vivo correlation.Development of validated RP HPLC method with fluorescence detection for simultaneous quantification of sacubitril and valsartan from rat plasmaFormulation and Evaluation of Chitosan-Based Buccal Bioadhesive Films of Zolmitriptan
P50
Q26750843-25ED6552-3C6F-45B3-B2D7-6E3EFE4C4845Q28069989-B085331D-367F-4CC8-BEC6-9D2EBDB7177EQ37133939-5C99B8DD-2993-4AD4-AB08-F0A8CE1C3038Q37691280-81963162-A85C-4F0C-9ADB-D0BD7D424008Q38065620-7E24E429-3E4D-4854-B7ED-2E34E07D119DQ38081518-C66321D4-4B65-4F61-A57F-6F670ED39AD9Q38144486-9D854855-84D2-47AF-B86C-48BDB15D4EC1Q38210197-4CABDABB-5BEE-4AC6-9615-2F6668DDD892Q38211641-530ACCFC-58D3-4C2F-97D2-DCCE374FB66BQ38211642-FC4CD9CA-DFFC-4FF2-BCD7-F07CD8FB398FQ38653518-C878D528-C677-49DE-AA0D-5AA45D7FE1C3Q38653933-0DCD2275-1D17-4444-A11C-98F73B5210CEQ38654050-7DD426E5-3867-42BC-9850-B55634995FE4Q39456079-2AB14EDD-DE3D-40D9-AAD0-C71BFBC15013Q40345485-0B5764C2-7C40-4D09-9D25-AE6587BADC59Q40830043-B27C4D74-F69B-4AB5-B525-E1D737CB9B99Q40865914-33297FE4-65C9-47C1-86D8-C884B1AAFED8Q41451480-9DE9292C-E2A4-4D26-BB8C-CDBECAA149CBQ41760699-717E4907-0226-4BCF-9FA1-9830A8DBCDA6Q42256499-8EFD3B7B-9B7D-430E-9F1F-A0F5EC591118Q43434203-5B162FEB-6FAF-45E0-BF29-73FB00D158E3Q43899224-61066097-B215-4CC7-902C-1E7C72ED3B87Q44561888-EEDD0DCD-C0D3-4B4D-A78F-18ADCA72015EQ44683770-778E18DB-EA33-487C-8F89-96277F589542Q44984934-D721F884-D246-4A6F-8317-F7F92FB935F4Q45152188-150862CB-FFDD-459B-8A20-F00B282E7DA4Q45209173-B8D1D9A4-8EC8-487A-B87F-4388F980FDC2Q45923936-CEF56CF1-C2E4-4C96-901E-83FECAF0B476Q45937466-78A0B052-C04A-4046-8DF3-EF4B6A5E28DBQ45989982-5E7298DD-F066-4580-921E-143284597DFBQ46052548-C63BA54E-7164-49D9-A8AD-77EFCB533BAEQ46064271-431AFF15-3BF8-45D9-AC63-21337F7BC527Q46082632-8F7A3C01-A77D-46B6-B36F-F117837AE1A7Q46831430-061CB01E-787D-4885-8A3E-7FE1D239A5D5Q47212608-7863264C-E09C-417A-947D-9D698B19AAEBQ51137706-42E39770-DCFD-4F90-A077-BB619D6CD27FQ51789805-9D9AED70-22EF-4C33-9AE1-27BC0A616ABCQ52309174-362443E9-3E10-4D21-AD66-D800E3F69114Q56035463-7DA8CDB4-2C17-4F48-A048-3388225D79B0Q56035467-31037BB7-2391-468E-BFA8-8C75DCC21088
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anroop Nair
@ast
Anroop Nair
@en
Anroop Nair
@es
Anroop Nair
@nl
Anroop Nair
@sl
type
label
Anroop Nair
@ast
Anroop Nair
@en
Anroop Nair
@es
Anroop Nair
@nl
Anroop Nair
@sl
prefLabel
Anroop Nair
@ast
Anroop Nair
@en
Anroop Nair
@es
Anroop Nair
@nl
Anroop Nair
@sl
P1153
P1053
L-9995-2014
P106
P1153
26221856600
57195713288
57199194713
P2798
P31
P3829
P3835
anroop-nair
P496
0000-0003-2850-8669